Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 28.

Journal Article

Becker, H. J., Reuter, S., Marquez, Garcia M., Schloesser, H. A., von Bergwelt-Baildon, M. and Theurich, S. (2016). B cells derived from patients with von Hippel-Lindau (VHL) disease display impaired antigen presentation upon CD40 activation. Oncol. Res. Treat., 39. S. 271 - 272. BASEL: KARGER. ISSN 2296-5262

Fischer, R. N., Abdulla, D., Michels, S., Nogova, L., Brandes, V, Scheffler, M., Schaeffer, S., Scheel, A., Thurat, M., Vehreschild, M., Thomas, R., von Bergwelt-Baildon, M., Buettner, R. and Wolf, J. (2016). Bioluma: Biomarkers for nivolumab and evaluation of nivolumab plus ipilimumab in lung cancer - A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response to immune checkpoint inhibition. Oncol. Res. Treat., 39. S. 92 - 94. BASEL: KARGER. ISSN 2296-5262

Fischer, R. N., George, J., Schaefer, S., Scheel, A., Schloesser, H., Vehreschild, M., von Bergwelt-Baildon, M., Nogova, L., Abdulla, D. S. Y., Michels, S., Riedel, R., Scheffler, M., Brossart, P., Engel-Riedel, W., Griesinger, F., Grohe, C., Kambartel, K., Kern, J., Kopp, H-G, Neukirchen, J., Overbeck, T. R., Panse, J., Sebastian, M., Serke, M., Wiewrodt, R., Buettner, R., Thomas, R. and Wolf, J. (2018). BIOLUMA: Biomarkers for nivolumab and evaluation of nivolumab plus ipilimumab in lung cancer. Oncol. Res. Treat., 41. S. 270 - 272. BASEL: KARGER. ISSN 2296-5262

Garcia-Marquez, M., Schloesser, H., Thelen, M., Zimmer, S. and von Bergwelt-Baildon, M. (2016). Characterization of infiltrating B cells in human colorectal and kidney cancer. Oncol. Res. Treat., 39. S. 157 - 158. BASEL: KARGER. ISSN 2296-5262

Kochanek, M., Shimabukuro-Vornhagen, A., Ruess, K., Beutel, G., Lueck, C., Kiehl, M., Schneider, R., Kroschinsky, F., Liebregts, T., Kluge, S., Schellongowski, P., von Bergwelt-Baildon, M. and Boell, B. (2020). Prevalence of cancer patients in German intensive care units. Med. Klin.-Intensivmed Notfallmed., 115 (4). S. 312 - 320. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226

Kochanek, Matthias ORCID: 0000-0002-4766-4651, Schalk, E., von Bergwelt-Baildon, M., Beutel, G., Buchheidt, D., Hentrich, M., Henze, L., Kiehl, M., Liebregts, T., von Lilienfeld-Toal, M., Classen, A., Mellinghoff, S., Penack, O., Piepel, C. and Boell, B. (2019). Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann. Hematol., 98 (5). S. 1051 - 1070. NEW YORK: SPRINGER. ISSN 1432-0584

Lechner, A., Schloesser, H., Rothschild, S., Thelen, M., Shimabukuro-Vornhagen, A., Beutner, D. and von Bergwelt-Baildon, M. (2016). Characterization of Tumor-associated B lymphocytes in head and neck squamous cell carcinoma. Oncol. Res. Treat., 39. S. 108 - 110. BASEL: KARGER. ISSN 2296-5262

Mellinghoff, S. C., Banck, J. C., Mueller, N., Thelen, M., Schloesser, H. A., Cornely, O. A. and von Bergwelt-Baildon, M. (2020). Immune checkpoint blockade for aspergillosis and mucormycosis co-infection. Mycoses, 63. S. 24 - 25. HOBOKEN: WILEY. ISSN 1439-0507

Pflug, N., Chakupurakal, G., Theurich, S., Holtick, U., Leitzke, S., Chemnitz, J., Scheid, C., Hallek, M. and von Bergwelt-Baildon, M. (2018). Addition of rituximab to nonmyeloablative allogeneic transplantation for CLL and Richter's transformation - a single center experience. Oncol. Res. Treat., 41. S. 102 - 103. BASEL: KARGER. ISSN 2296-5262

Prinz, J., Goedel, P., Shimabukuro-Vornhagen, A., von Bergwelt-Baildon, M., Kochanek, M., Borchmann, P. and Boell, B. (2018). Immune-related toxicity syndromes in patients treated with chimeric antigen receptor T cell therapy. Oncol. Res. Treat., 41. S. 87 - 88. BASEL: KARGER. ISSN 2296-5262

Probst, L., Kochanek, M., Shimabukuro-Vornhagen, A., von Bergwelt-Baildon, M., Vehreschild, J. J., Prinz, J. and Boell, B. (2018). Predictive accuracy of sepsis scores in hematological patients. Oncol. Res. Treat., 41. S. 209 - 210. BASEL: KARGER. ISSN 2296-5262

Scheid, C., Chemnitz, J., Herling, M., Pflug, N., Theurich, S., Burst, A., Leitzke, S., von Bergwelt-Baildon, M., Hallek, M. and Holtick, U. (2016). A ROLE FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN THE ERA OF NOVEL AGENTS FOR HODGKIN'S LYMPHOMA? Haematologica, 101. S. 55 - 57. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Schloesser, H. A., Thelen, M., Dieplinger, G., von Bergwelt-Baildon, A., Heiermann, N., Kleinert, R., Wahba, R., Ditt, V., Kurschat, C., Cingoez, T., Becker, J., Stippel, D. and von Bergwelt-Baildon, M. (2016). PROSPECTIVE ANALYSES OF CIRCULATING B-CELL SUBSETS IN ABO-COMPATIBLE AND ABO-INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENTS. Transpl. Int., 29. S. 44 - 45. HOBOKEN: WILEY-BLACKWELL. ISSN 1432-2277

Schloesser, H. A., Thelen, M., Lechner, A., Gilles, R., Garcia-Marquez, M., Wennhold, K., Alakus, H., Schroeder, W., Moenig, S., Theurich, S., Shimabukuro-Vornhagen, A., Gathof, B., Drebber, U., Quaas, A., Bruns, C., Hoelscher, A. H. and von Bergwelt-Baildon, M. (2017). Tumor-associated B cells and humoral immune response in esophago-gastric adenocarcinoma. Oncol. Res. Treat., 40. S. 159 - 160. BASEL: KARGER. ISSN 2296-5262

Schlosser, H. A., Thelen, M., Dieplinger, G., von Bergwelt-Baildon, A., Garcia-Marquez, M., Reuter, S., Shimabukuro-Vornhagen, A., Wennhold, K., Haustein, N., Buchner, D., Heiermann, N., Kleinert, R., Wahba, R., Ditt, V., Kurschat, C., Cingoz, T., Becker, J., Stippel, D. L. and von Bergwelt-Baildon, M. (2017). Prospective Analyses of Circulating B Cell Subsets in ABO-Compatible and ABO-Incompatible Kidney Transplant Recipients. Am. J. Transplant., 17 (2). S. 542 - 551. HOBOKEN: WILEY. ISSN 1600-6143

Shimabukuro-Vornhagen, A., Zoghi, S. and von Bergwelt-Baildon, M. (2017). Identification of the mevalonate pathway as a potential therapeutic target for EBV-reactivation and PTLD. Oncol. Res. Treat., 40. S. 263 - 264. BASEL: KARGER. ISSN 2296-5262

Suarez, I., Boell, B., Shimabukuro-Vornhagen, A., Michels, G., von Bergwelt-Baildon, M. and Kochanek, M. (2016). Mortality of hematology-oncology patients with neutropenia in intensivecare. Med. Klin.-Intensivmed Notfallmed., 111 (2). S. 84 - 92. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226

Thelen, M., Lechner, A., Schloesser, H., Rothschild, S., Wennhold, K., Beutner, D. and von Bergwelt-Baildon, M. (2017). Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma (HNSCC). Oncol. Res. Treat., 40. S. 251 - 252. BASEL: KARGER. ISSN 2296-5262

Theurich, S., Becker, H. J., Malcher, J., Marquez, M. G., Wennhold, K., Reuter, S., Shimabukuro-Vornhagen, A., Schloesser, H. A., Huelsemann, M., Frenzel, L. P. and von Bergwelt-Baildon, M. (2017). Hypoxia and iron-chelation decrease antigen-presenting functions in CD40-activated human B cells. Oncol. Res. Treat., 40. S. 255 - 256. BASEL: KARGER. ISSN 2296-5262

Theurich, S., Iltgen, J., Wennhold, K., Marquez, M. Garcia, Rothschild, S., Schneider, B., Holtick, U., Thelen, M., Scheid, C., Becker, Hj, Schloesser, H., Reuter, S., Vornhagen, A. Shimabukuro and von Bergwelt-Baildon, M. (2016). THE JAK1/2 INHIBITOR RUXOLITINIB MODULATES ANTIGEN PRESENTING FUNCTIONS OF ACTIVATED PRIMARY B CELLS ON A METABOLIC LEVEL. Haematologica, 101. S. 462 - 463. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Theurich, S., Iltgen-Brebuda, J., Thelen, M., Wennhold, K., Rothschild, S., Becker, H., Schloesser, H., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2017). Ruxolitinib modulates the antigen presenting function of activated B cells by interfering with metabolic pathways. Oncol. Res. Treat., 40. S. 262 - 263. BASEL: KARGER. ISSN 2296-5262

Theurich, S., Rothschild, S. I., Hoffmann, M., Fabri, M., Sommer, A., Marquez, M. Garcia, Thelen, M., Schill, C., Merki, R., Schmid, T., Koeberle, D., Zippelius, A., Baues, C., Mauch, C., Tigges, C., Kreuter, A., von Bergwelt-Baildon, M. and Schlaak, M. (2016). Cytotoxic local tumor treatment in combination with xystemic Ipilimumab enhances the efficacy of this immunotherapy and prolongs overall survival in patients with advanced malignant melanoma. Oncol. Res. Treat., 39. S. 8 - 9. BASEL: KARGER. ISSN 2296-5262

Theurich, S., Rothschild, S., I, Hoffmann, M., Fabri, M., Sommer, A., Garcia-Marquez, M., Thelen, M., Schill, C., Merki, R., Schmid, T., Koeberle, D., Zippelius, A., Baues, C., Mauch, C., Tigges, C., Kreuter, A., Borggrefe, J., Schlaak, M. and von Bergwelt-Baildon, M. (2016). Local treatment of tumors or metastases in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. Oncol. Res. Treat., 39. S. 103 - 105. BASEL: KARGER. ISSN 2296-5262

Trommer-Nestler, M., Yeo, S. Y., Marnitz, S., Persigehl, T., Bunck, A., Schlaak, M., Gruell, H., Theurich, S., von Bergwelt-Baildon, M., Herter, J., Celik, E., Rosenbrock, J. and Baues, C. (2018). Abscopal effects in metastasized cancer patients treated with PD-1 inhibition and radiation therapy. Strahlenther. Onkol., 194. S. S200 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Wennhold, K., Thelen, M., Garcia-Marquez, M., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2016). Tumorantigen-specific CD40B cells - combining enhanced antigen-presentation and antibody-secretion for tumor targeting. Oncol. Res. Treat., 39. S. 7 - 8. BASEL: KARGER. ISSN 2296-5262

Wennhold, K., Thelen, M., Lechner, A., Schloesser, H. and von Bergwelt-Baildon, M. (2018). CD86+antigen-presenting B cells are increased in solid cancers and induce tumor antigen-specific T cell responses. Oncol. Res. Treat., 41. S. 235 - 236. BASEL: KARGER. ISSN 2296-5262

Wennhold, K., Thelen, M., Schloesser, H., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2017). Using antigen-specific B cells to combine antibody and T cell based cancer immunotherapy. Oncol. Res. Treat., 40. S. 241 - 242. BASEL: KARGER. ISSN 2296-5262

Zimmer, S., Schloesser, H., Wennhold, K., Thelen, M., Garcia-Marquez, M. and von Bergwelt-Baildon, M. (2016). Characterization of B-cell subsets in renal cell carcinoma. Oncol. Res. Treat., 39. S. 19 - 20. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Feb 25 02:23:19 2021 CET.